New study explores digital tools to keep care going in crises
NCT ID NCT06735404
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looks at whether a hybrid care model—using telemonitoring, teleconsultations, and online tools—can help patients with type 2 diabetes or chronic heart failure get regular care during health emergencies like pandemics. Researchers will follow 180 patients for one year, using surveys and interviews to see how patients feel about this approach. The goal is to learn if this model can reduce strain on healthcare systems while keeping patients safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
hybrid care model (digital tools and task shifting)
What this could lead to
If successful, this could show that a mix of digital tools and remote care can keep regular care running smoothly during future health emergencies.
What could go wrong
This is a small feasibility study, not a large trial. It only measures patient experiences, not hard health outcomes, so results may not prove the model works for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accademia Italiana Cure Primarie
Verona, Italy
Contact Email: •••••@•••••
-
Community Health Centre Ljubljana
Ljubljana, Slovenia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Radboud University Medical Center
Nijmegen, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Malta
Valletta, Malta
Contact Phone: •••-•••-•••• Email: •••••@•••••